Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127775521 | 12777552 | 1 | I | 2011 | 20160331 | 20160924 | 20160924 | PER | US-TEVA-648931USA | TEVA | 0.00 | F | Y | 61.29000 | KG | 20160924 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127775521 | 12777552 | 1 | PS | CLONAZEPAM. | CLONAZEPAM | 1 | Oral | .5 MILLIGRAM DAILY; TAKE ONE TABLET BY MOUTH EVERY EVENING FOR SLEEP. | U | 74569 | .5 | MG | TABLET | QD | |||||
127775521 | 12777552 | 2 | SS | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Unknown | U | 71523 | 100 | MG | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127775521 | 12777552 | 1 | Sleep disorder |
127775521 | 12777552 | 2 | Sleep disorder |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127775521 | 12777552 | Anxiety | |
127775521 | 12777552 | Fear | |
127775521 | 12777552 | Obsessive-compulsive disorder | |
127775521 | 12777552 | Product use issue | |
127775521 | 12777552 | Stress | |
127775521 | 12777552 | Thinking abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127775521 | 12777552 | 1 | 2011 | 0 | ||
127775521 | 12777552 | 2 | 2011 | 0 |